Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Relative Value
The Relative Value of one Beijing Kawin Technology Share-holding Co Ltd stock under the Base Case scenario is 32.19 CNY. Compared to the current market price of 29.54 CNY, Beijing Kawin Technology Share-holding Co Ltd is Undervalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Beijing Kawin Technology Share-holding Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
|
4.9B CNY | 3.5 | 42.1 | 26.5 | 26.5 | ||
US |
Abbvie Inc
NYSE:ABBV
|
284.8B USD | 5.2 | 59.1 | 12.8 | 19.6 | ||
US |
Amgen Inc
NASDAQ:AMGN
|
165.5B USD | 5.6 | 44 | 18.6 | 30.6 | ||
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD | 11.2 | 30.6 | 24.7 | 25.9 | ||
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
107.5B USD | 8.2 | 27.9 | 22.5 | 25 | ||
AU |
CSL Ltd
ASX:CSL
|
135.2B AUD | 6.3 | 36.2 | 21.9 | 27.1 | ||
US |
Gilead Sciences Inc
NASDAQ:GILD
|
84B USD | 3.1 | 173.5 | 7 | 9.1 | ||
US |
Moderna Inc
NASDAQ:MRNA
|
48.2B USD | 9.4 | -8.1 | -8.8 | -7.8 | ||
US |
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | ||
US |
Biogen Inc
NASDAQ:BIIB
|
32.7B USD | 3.4 | 28 | 14.3 | 17.9 | ||
KR |
Celltrion Inc
KRX:068270
|
39.5T KRW | 18.2 | 73.8 | 45.2 | 62.2 |